Ginkgo Bioworks Holdings (DNA) EPS (Basic) (2020 - 2026)
Ginkgo Bioworks Holdings' (DNA) quarterly EPS (Basic) came in at -$0.11 in Q1 2026, up 22.26% YoY from -$0.09 in Q1 2025, and up 92.47% on a QoQ basis from -$1.46 in Q4 2025.
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) EPS (Basic) (2020 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has 7 years of EPS (Basic) data on file, last reported at -$0.11 in Q1 2026.
- Quarterly EPS (Basic) rose 22.26% year-over-year to -$0.11 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.83 (up 46.51% YoY) and the FY2025 annual result came in at -$5.64, up 46.5% from the prior year.
- EPS (Basic) grew to -$0.11 in Q1 2026, from -$1.46 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.11 in Q1 2026 to a low of -$4281.4 in Q1 2023.
- A 5-year average of -$256.61 and a median of -$3.59 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) sank 29037.74% — and 2024, when it jumped 99.92%.
- Tracing DNA's EPS (Basic) over 5 years: stood at -$4.12 in 2022, then dropped by 5.62% to -$4.35 in 2023, then jumped by 52.42% to -$2.07 in 2024, then gained by 29.73% to -$1.46 in 2025, then jumped by 92.47% to -$0.11 in 2026.
- The last three EPS (Basic) figures came in at -$0.11 (Q1 2026), -$1.46 (Q4 2025), and -$1.45 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Ginkgo Bioworks Holdings | 428.45 Mn | 343.92 Mn | 18.44 Mn | -0.75 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.75 |
| Mar 31, 2026 | -1.39 |
| Dec 31, 2025 | -1.46 |
| Sep 30, 2025 | -1.45 |
| Jun 30, 2025 | -1.10 |
| Mar 31, 2025 | -1.68 |
| Dec 31, 2024 | -2.07 |
| Sep 30, 2024 | -1.08 |
| Jun 30, 2024 | -4.23 |
| Mar 31, 2024 | -3.31 |
| Dec 31, 2023 | -4.35 |
| Sep 30, 2023 | -6.21 |
| Jun 30, 2023 | -3.59 |
| Mar 31, 2023 | -4.28 |
| Dec 31, 2022 | -4.12 |
| Sep 30, 2022 | -16.44 |
| Jun 30, 2022 | -16.55 |
| Mar 31, 2022 | -14.69 |
| Dec 31, 2021 | -47.21 |
| Sep 30, 2021 | -3.09 |